Team:TAS Taipei/project/overview
From 2014hs.igem.org
Xiaoyangkao2 (Talk | contribs) |
Xiaoyangkao2 (Talk | contribs) |
||
Line 99: | Line 99: | ||
<div class='subcategories_container'> | <div class='subcategories_container'> | ||
<div> | <div> | ||
- | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/modeling | + | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/modeling#telomere_extension">Telomere Extension</a></h5> |
</div> | </div> | ||
<div> | <div> | ||
- | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/modeling | + | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/modeling#circuit_regulation">Circuit Regulation</a></h5> |
</div> | </div> | ||
<div> | <div> | ||
- | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/modeling | + | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/modeling#safety_switch">Safety Switch</a></h5> |
</div> | </div> | ||
</div> | </div> | ||
Line 119: | Line 119: | ||
<div class='subcategories_container'> | <div class='subcategories_container'> | ||
<div> | <div> | ||
- | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/human_practice | + | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/human_practice#research">Research</a></h5> |
</div> | </div> | ||
<div> | <div> | ||
- | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/human_practice | + | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/human_practice#entertainment">Entertainment</a></h5> |
</div> | </div> | ||
<div> | <div> | ||
- | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/human_practice | + | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/human_practice#outreach">Outreach</a></h5> |
</div> | </div> | ||
</div> | </div> | ||
Line 140: | Line 140: | ||
</li> | </li> | ||
<li class="dropdown"> | <li class="dropdown"> | ||
- | <a href="https://2014hs.igem.org/Team:TAS_Taipei/team | + | <a href="https://2014hs.igem.org/Team:TAS_Taipei/team"><h4 class='dropdown-toggle disabled' data-toggle="dropdown">TEAM</h4></a> |
<div class="dropdown-menu"> | <div class="dropdown-menu"> | ||
<div style='height:100px;'> | <div style='height:100px;'> | ||
Line 148: | Line 148: | ||
<div class='subcategories_container'> | <div class='subcategories_container'> | ||
<div> | <div> | ||
- | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/team | + | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/team#members">Members</a></h5> |
</div> | </div> | ||
<div> | <div> | ||
- | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/about">About</a></h5> | + | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/team#about">About</a></h5> |
</div> | </div> | ||
<div> | <div> | ||
Line 160: | Line 160: | ||
</li> | </li> | ||
<li class="dropdown"> | <li class="dropdown"> | ||
- | <a href="https://2014hs.igem.org/Team: | + | <a href="https://2014hs.igem.org/Team:TAS_Taipei/notebook"><h4 class='dropdown-toggle disabled' data-toggle="dropdown">NOTEBOOK</h4></a> |
<div class="dropdown-menu"> | <div class="dropdown-menu"> | ||
<div style='height:100px;'> | <div style='height:100px;'> | ||
Line 168: | Line 168: | ||
<div class='subcategories_container'> | <div class='subcategories_container'> | ||
<div> | <div> | ||
- | <h5><a href="https://2014hs.igem.org/Team: | + | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/notebook#experiments">Experiments</a></h5> |
</div> | </div> | ||
<div> | <div> | ||
- | <h5><a href="https://2014hs.igem.org/Team: | + | <h5><a href="https://2014hs.igem.org/Team:TAS_Taipei/notebook#calendar">Calendar</a></h5> |
</div> | </div> | ||
</div> | </div> |
Revision as of 03:37, 21 June 2014
Project Overview
Telomeres are repeating sequences of TTAGGG nucleotides at the ends of somatic cell chromosomes. These sequences protect cellular genomes from harmful effects associated with chromosome shortening during cell replication. Due to the finite length of telomeres, telomere shortening is known to be a primary contributor to cellular senescence and cell death. To allow human somatic cells to replicate indefinitely, we have engineered a biological circuit with three primary components to regulate telomere length. (1) Expression of the reverse transcriptase enzyme telomerase to extend telomeres (2) Regulation of the amount of telomerase expressed using an oscillatory mechanism (3) Operation of a safety device to prevent possible cancerogenesis. Through the cooperation of these three mechanisms, and the tools of synthetic biology, lifespan extension is possible.